Dormant TILs and Sensitivity to Immune Checkpoint Blockers in Lung Cancer
Demographics (1)
- SEX - Sex of Participant (phv00389836.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for Non-Small Cell Lung Cancer (phv00389831.v1.p1)
Race and Ethnicity (2)
- ETHNICITY - Ethnicity of Participant (phv00389838.v1.p1)
- RACE - Race of Participant (phv00389837.v1.p1)
Substance Use (1)
- SMOKING_PACK_YEARS - Smoking History in Pack Years (phv00389839.v1.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type of Sample (phv00389844.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00389830.v1.p1)
- HISTOLOGICAL_TYPE - Tissue Type or Subtype of Sample (phv00389845.v1.p1)
- ICI_TREATMENT - Immune Checkpoint Inhibitor Therapy Received by Participant (phv00389842.v1.p1)
- IS_TUMOR - Tumor Status of Sample (phv00389846.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00389843.v1.p1)
- SAMPLE_ID - Sample ID (phv00389833.v1.p1)
- SAMPLE_USE - Sample Use (phv00389834.v1.p1)
- SEQUENCING_CENTER - Name of the Center Which Conducted Sequencing (phv00389848.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00389835.v1.p1)
- SUBJECT_ID - Subject ID (phv00389829.v1.p1)
- SUBJECT_ID - Subject ID (phv00389832.v1.p1)
- TUMOR_COLLECTION_TIMEPOINT - Treatment Timepoint at which Sample was Collected (phv00389847.v1.p1)
- TUMOR_HISTOLOGY - Histology of Tumor (phv00389840.v1.p1)
- TUMOR_ONCOGENIC_DRIVER - Oncogenic Driver Alteration Present in Tumor (Entrez Gene IDs: 1956, 3845) (phv00389841.v1.p1)